Marizyme (MRZM) Financial Statements
Marizyme Financial Overview
Marizyme's market cap is currently $132. The company's EPS TTM is $-0.28; its P/E ratio is 0.00; Marizyme has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 645.81K | $ 233.49K | $ 210.28K | $ 197.14K | $ 0.00 |
| Gross Profit | $ 238.91K | $ 179.17K | $ 129.93K | $ 138.84K | $ 0.00 |
| Operating Income | $ -34.09M | $ -12.97M | $ -8.82M | $ -5.80M | $ -1.06M |
| EBITDA | $ -55.44M | $ -34.54M | $ -10.83M | $ -5.21M | $ 0.00 |
| Net Income | $ -69.54M | $ -38.17M | $ -11.00M | $ -5.85M | $ -1.06M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 148.47K | $ 510.87K | $ 4.07M | $ 2.90M | $ 90.00 |
| Total Assets | $ 22.02M | $ 38.69M | $ 66.00M | $ 47.08M | $ 28.61M |
| Total Debt | $ 20.76M | $ 5.37M | $ 1.78M | $ 1.32M | $ 0.00 |
| Net Debt | $ 20.61M | $ 4.86M | $ -2.29M | $ -1.58M | $ -90.00 |
| Total Liabilities | $ 28.72M | $ 21.27M | $ 18.31M | $ 1.80M | $ 270.22K |
| Stockholders' Equity | $ -4.66M | $ 17.42M | $ 47.69M | $ 45.29M | $ 28.34M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.68M | $ -10.85M | $ -5.79M | $ -3.37M | $ -125.01K |
| Operating Cash Flow | $ -4.68M | $ -10.85M | $ -5.79M | $ -3.22M | $ -112.01K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ -148.66K | $ -13.00K |
| Financing Cash Flow | $ 4.32M | $ 7.29M | $ 6.96M | $ 6.28M | $ 125.00K |
Currency in USD
